🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Weave Communications, Inc. WEAV R2K

Healthcare · Health Information Services · United States
https://www.getweave.com

Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses. It offers AI-receptionist; Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manage heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging and SMS response assistant; Missed Call Text that allows practices to respond when a call is missed; Missed Text Auto-Reply that replies to patient text messages by automatically responding to messages received outside of a practice's normal operating hours; Team Chat, a group messaging solution; and Weave Mobile App. It also provides Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant to create professional emails; Text Connect to interact with their patients online directly through their websites; and Weave Payments, a payment processing solution. The company provides Weave Digital Forms to collect patient information; Online Scheduling that allows patients to request appointments from the practice's website, send automatic scheduling reminders, and personalize each reminder for the patient; Insurance Eligibility, an insurance tool; Insurance Verification; Practice Analytics that provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; Call Intelligence; and Weave Enterprise for multi-location healthcare practices comprising dental service organizations, vision, veterinary, and medical groups. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.

READ MORE ›
$6.02
-37.62% 1Y

Market & Price

Market Cap
$478.99M
Current Price
$6.02
High / Low (52W)
$9.91 / $4.37
Beta
1.63

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
25.62
PEG Ratio
-
Book Value
$1.05
Price to Book
5.73
P/S
1.93
EV/EBITDA
-30.03
Dividend Yield
-

Profitability & Returns

ROCE
-22.11%
ROE
-32.92%
ROA
-8.19%
Profit Margin
-10.05%
Op Margin
-8.80%
EPS (Latest Qtr)
$-0.07
EPS (TTM)
$-0.32

Balance Sheet & Liquidity

Debt/Equity
0.62
Quick Ratio
0.95
Current Ratio
1.24
Debt
$51.29M
Total Assets
$207.97M
Current Assets
$104.99M
Working Capital
$20.40M

Ownership

Promoter Holding
9.39%
Chg in Prom Hold
-
FII / Inst Holding
88.50%
Chg in FII Hold
0.05%

Financial Snapshot

Enterprise Value
$457.57M
Total Revenue (TTM)
$248.72M
EBITDA
$-15.24M
Free Cash Flow
$39.84M
Operating Cash Flow
$12.05M
Shares Outstanding
79.57M
Gross Margin
72.34%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
18.92%
Profit 5Y
14.53%
Revenue (YoY)
17.40%
Earnings (YoY)
-

PROS

  • Compounding revenue at 18.9% over 5 years.
  • Profit CAGR of 14.5% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading 39.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 WEAV Weave Communications, Inc. R2K 6.02 - $478.99M - -22.11% -32.92% 18.92% 14.53%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 21.39M25.67M-30.30M-33.27M--------55.81M58.47M61.34M63.40M65.50M
Cost of Revenue --------------15.86M16.52M17.00M17.33M17.96M
Gross Profit 12.17M14.87M16.04M17.43M-19.52M21.18M23.21M26.53M28.04M29.93M32.99M36.12M37.73M39.95M41.95M44.34M46.07M47.54M
Operating Expenses --------------49.27M52.14M53.29M48.23M53.56M
Operating Income -10.15M-8.71M-14.13M-13.90M--13.51M-14.59M-11.86M-8.52M-9.83M-8.02M-8.15M-9.26M-6.63M-9.32M-10.19M-8.94M-2.16M-6.02M
EBITDA ---------------4.57M-5.26M-3.95M3.00M-772.00K
Interest Expense --------------397.00K537.00K366.00K400.00K369.00K
Pretax Income ---------------8.75M-9.82M-8.59M-1.82M-5.67M
Tax Provision --------------71.00K-1.11M82.00K29.00K102.00K
Net Income -10.40M-8.98M-14.42M-14.22M--13.84M-14.81M-11.82M-7.86M-8.99M-7.14M-7.20M-8.55M-5.88M-8.82M-8.71M-8.67M-1.85M-5.77M
Diluted EPS -0.95-0.79-1.12-1.03-2.60-0.21-0.23-0.18-0.12-0.13-0.10-0.10-0.12-0.08-0.12-0.11-0.11-0.02-0.07
R&D Expense 5.41M5.84M7.87M6.18M-7.20M7.43M7.90M7.69M8.59M8.63M9.64M9.96M9.87M11.15M11.99M13.12M-10.81M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 45.75M79.90M-142.12M170.47M204.31M239.02M
Cost of Revenue ---53.28M54.38M58.43M66.72M
Gross Profit 27.23M45.45M-88.84M116.09M145.88M172.31M
Operating Expenses ---138.54M150.46M177.29M202.92M
Operating Income -31.92M-39.57M--49.70M-34.37M-31.41M-30.61M
EBITDA ----31.55M-13.02M-11.17M-10.78M
Interest Expense ---1.44M1.92M1.52M1.70M
Pretax Income ----49.63M-30.77M-28.16M-28.98M
Tax Provision ---104.00K260.00K189.00K-924.00K
Net Income -32.06M-40.42M--49.74M-31.03M-28.35M-28.05M
Diluted EPS -3.30-3.75--0.76-0.46-0.40-0.37
R&D Expense 14.41M19.97M27.01M30.71M34.04M40.23M44.46M

Compounded Sales Growth

5 Years:18.92%
1 Year:17.40%

Compounded Profit Growth

5 Years:14.53%
1 Year:-

Stock Price Performance

1 Year:-37.62%
6 Months:-4.60%
3 Months:+19.44%
1 Month:+24.38%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --92.97M-208.35M201.01M188.93M207.97M
Current Assets ----132.89M129.78M120.74M104.99M
Cash & Equivalents --55.70M-62.00M50.76M51.60M54.96M
Inventory --------
Receivables ----3.30M3.51M3.74M4.35M
Total Liabilities --54.98M-125.13M122.06M121.96M125.58M
Current Liabilities --44.02M-72.22M72.85M76.62M84.60M
Long Term Debt --3.60M10.00M----
Total Debt ----73.56M59.54M56.06M52.15M
Total Equity -61.91M-85.99M-113.94M-83.22M78.96M66.97M82.38M
Shares Outstanding ----65.74M70.12M73.23M78.35M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -22.07M-15.52M--12.77M10.22M14.15M17.54M
Investing Cash Flow -2.47M-3.86M--54.03M-7.74M8.88M-6.85M
Financing Cash Flow 65.00M-5.15M--7.21M-13.72M-22.19M-7.33M
Capital Expenditure -2.47M-2.76M--3.13M-3.69M-3.79M-4.68M
Free Cash Flow -24.54M-18.28M--15.89M6.53M10.36M12.86M
Net Change in Cash ----74.00M-11.24M840.00K3.36M
Share Buybacks 1.41M00----

Ratios (Annual)

Figures in %.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 59.5%56.9%-62.5%68.1%71.4%72.1%
Operating Margin % -69.8%-49.5%--35.0%-20.2%-15.4%-12.8%
Net Margin % -70.1%-50.6%--35.0%-18.2%-13.9%-11.7%
ROE % 37.3%35.5%--59.8%-39.3%-42.3%-34.1%
ROCE % --80.8%--36.5%-26.8%-28.0%-24.8%

Shareholding Pattern

Insiders
9.39%
Institutions
88.50%
Public Float
97.67%

Top Institutional Holders

#Holder% HeldSharesValue
1 Newtyn Management, Llc 8.80% 7.00M $42.14M
2 Blackrock Inc. 5.93% 4.72M $28.42M
3 Crosslink Capital Inc 5.34% 4.25M $25.57M
4 Gumshoe Capital Management LLC 3.86% 3.07M $18.48M
5 Vanguard Capital Management LLC 3.47% 2.76M $16.62M
6 Vanguard Portfolio Management LLC 3.05% 2.43M $14.62M
7 Disciplined Growth Investors, Inc. 2.86% 2.28M $13.70M
8 State Street Corporation 2.76% 2.19M $13.20M
9 Frontier Capital Management Company LLC 2.64% 2.10M $12.64M
10 Divisar Capital Management LLC 2.31% 1.84M $11.08M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for WEAV

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks